A platform for research: civil engineering, architecture and urbanism
A platform for research: civil engineering, architecture and urbanism
Prebiotics and Postbiotics Synergistic Delivery Microcapsules from Microfluidics for Treating Colitis
Manipulation of gut microbiota by bacterial metabolites has shown protective effects against colitis; while the efficacy is strictly limited by the poor oral delivery efficiency and single drug usage. Here, a novel prebiotics and postbiotics synergistic delivery microcapsule composed of indole‐3‐propionic acid (IPA) postbiotic and three prebiotics including alginate sodium, resistant starch (RS), and chitosan via microfluidic electrospray for preventing and treating colitis are proposed. It is found that oral administration of IPA microcapsules (IPA@MC) to mice can exert significant protective effects to colitis, suggesting the therapeutic synergy between prebiotics and postbiotics. Furthermore, the mechanism of the IPA@MC is revealed in modulating the gut microbiota, that is by significantly increasing the overall richness and abundance of short‐chain fatty acids (SCFA) producing bacteria such as Faecalibacterium and Roseburia. These results indicate that the prebiotics and postbiotics synergistic delivery microcapsules are ideal candidates for treating colitis.
Prebiotics and Postbiotics Synergistic Delivery Microcapsules from Microfluidics for Treating Colitis
Manipulation of gut microbiota by bacterial metabolites has shown protective effects against colitis; while the efficacy is strictly limited by the poor oral delivery efficiency and single drug usage. Here, a novel prebiotics and postbiotics synergistic delivery microcapsule composed of indole‐3‐propionic acid (IPA) postbiotic and three prebiotics including alginate sodium, resistant starch (RS), and chitosan via microfluidic electrospray for preventing and treating colitis are proposed. It is found that oral administration of IPA microcapsules (IPA@MC) to mice can exert significant protective effects to colitis, suggesting the therapeutic synergy between prebiotics and postbiotics. Furthermore, the mechanism of the IPA@MC is revealed in modulating the gut microbiota, that is by significantly increasing the overall richness and abundance of short‐chain fatty acids (SCFA) producing bacteria such as Faecalibacterium and Roseburia. These results indicate that the prebiotics and postbiotics synergistic delivery microcapsules are ideal candidates for treating colitis.
Prebiotics and Postbiotics Synergistic Delivery Microcapsules from Microfluidics for Treating Colitis
Yang, Keli (author) / Wang, Xiaocheng (author) / Huang, Rongkang (author) / Wang, Hui (author) / Lan, Ping (author) / Zhao, Yuanjin (author)
Advanced Science ; 9
2022-05-01
11 pages
Article (Journal)
Electronic Resource
English
Self-rupturing microcapsules for pulsed drug delivery
| British Library Online Contents | 2005
Modulation of skin microbiota by topical prebiotics
| British Library Online Contents | 2015
Multi‐Bioinspired MOF Delivery Systems from Microfluidics for Tumor Multimodal Therapy
| Wiley | 2023